Generic Pharmaceuticals Pricing Antitrust Litigation

This multi-district litigation addresses price-fixing among generic drug manufacturers affecting over 180 generic medications. Multiple settlements have been approved.

Who Qualifies

• Direct purchasers: pharmacies, hospitals, and clinics that bought generic drugs directly from manufacturers or distributors
• Indirect reseller plaintiffs: dispensers (pharmacies, hospitals) that purchased covered drugs between January 2010 and March 2024
• End-payer class: insurers, employer health plans, and union health funds that reimbursed inflated generic drug costs
• Self-insured employers with health plans covering any of the 180+ affected generics (clobetasol, levothyroxine, and others)

What RDL Does for You

Filing a settlement claim correctly requires attention to documentation, deadlines, and administrator follow-up. Most businesses either don't know they qualify, miss the deadline, or submit incomplete claims that get rejected. RDL eliminates those risks:

• We assess your eligibility across multiple settlement tracks
• We monitor for new settlement opportunities
• We prepare and file claims for each applicable settlement
• We track distributions across all relevant cases